CEO Total Pay
$15.5M
FY2025 Summary Compensation, above median
The CEO earned $15.5M in FY2025 against median worker pay of $56,427 · Health Services.
Data updated August 2026
Subscribe to Quest Diagnostics Inc CEO pay filing updates (RSS)
Answer first
According to the same FY2025 complete-filing cohort used on the rankings boards (CEO total, median worker, and ratio all present). Median worker pay is $56,427. Industry placement uses the FY2025 SIC-80 peer cohort (# 9 of 31, 74th percentile - above the industry median pay ratio). Figures come from Section 953(b) Dodd-Frank DEF 14A disclosures - not estimates. View all Health Services companies.
Quest Diagnostics Inc CEO pay vs. every FY2025 complete filing
Total CEO compensation, the full national distribution, this company marked
$15,521,601 Top 20% higher than 80% of 1,423 companies
Each bar is a $2500K-wide band; taller bars hold more companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source SEC DEF 14A Section 953(b) disclosures, PlainCEOPay extract · FY2025
CEO total pay ($15.5M) against pay ratio (275:1) for Quest Diagnostics Inc (marked) and its 5 closest same-industry peers, against the Health Services industry median on both axes.
Exclusive CEO-to-median-worker bands across 29 complete latest-FY filings in SIC 80. Segments sum to the peer set, not this company's compensation pillar.
A component-level pay breakdown is not reported in Quest Diagnostics Inc's structured SEC pay-ratio disclosure. See our methodology →
Complete DEF 14A pay-ratio filings for this CIK across FY2022–2025. Year-over-year deltas compare adjacent filing years only; incomplete dollar rows are omitted (same completeness gate as the hero figures).
| FY | CEO pay | Δ pay | Median worker | Pay ratio | Δ ratio |
|---|---|---|---|---|---|
| 2022 | $11.9M | - | $63,854 | 1:1 | - |
| 2023 | $12.7M | +6.7% | $68,163 | 186:1 | +185:1 |
| 2024 | $14.4M | +14% | $59,575 | 242:1 | +56:1 |
| 2025 | $15.5M | +7.6% | $56,427 | 275:1 | +33:1 |
Source: SEC EDGAR DEF 14A pay-ratio disclosures for CIK 1022079, FY2022–2025. Adjacent-year deltas only.
Quest Diagnostics Inc's FY2025 ratio 275:1 ranks #9 of 31 Health Services filers (74th percentile). the CEO earned 275× the median employee ($56,427) in FY2025.
Median employee $56,427 (PAR-MED); STEEP · PEAK stamps put about 275 median-wage years per CEO year.
CEO Total Pay
$15.5M
FY2025 Summary Compensation, above median
Pay Ratio
275:1
Elevated vs. peers
Quest Diagnostics Inc's FY2025 ratio 275:1 ranks #9 of 31 Health Services filers (74th percentile). The structured pay-ratio disclosure reports the total without line-item components. Health Services (SIC 80) median ratio is 129:1 across 31 FY2025 filers; Quest Diagnostics Inc's $15.5M CEO total is above the $10.2M industry median CEO pay.
Dollar rank #283 and ratio rank #219 split - treat 275:1 as a disclosure, not a fairness score. Open Health Services peers.
Read our methodology - how this data is sourced, computed, and verified. Quest Diagnostics Inc's FY2025 ratio 275:1 ranks #9 of 31 Health Services filers (74th percentile).
ABS(ceo_total_comp) peers first, then a SIC pole and a stamp-branched guide - not a fixed Related strip. This page stamps STEEP · PEAK · PAR-MED.
ABS(ceo_total_comp) peer at $15.5M (Δ $20K lighter vs Quest Diagnostics Inc); MID · ELITE-MED vs this page's STEEP · PEAK · PAR-MED.
ABS(ceo_total_comp) peer at $15.5M (Δ $21K lighter vs Quest Diagnostics Inc); MID · ELITE-MED vs this page's STEEP · PEAK · PAR-MED.
ABS(ceo_total_comp) peer at $15.5M (Δ $22K heavier vs Quest Diagnostics Inc); MID · ELITE-MED vs this page's STEEP · PEAK · PAR-MED.
ABS(ceo_total_comp) peer at $15.5M (Δ $64K lighter vs Quest Diagnostics Inc); EXTREME · LOW-MED vs this page's STEEP · PEAK · PAR-MED.
Universal Health Services Inc stamps STEEP · PEAK nearest in-SIC by ABS(pay_ratio) to Quest Diagnostics Inc's STEEP filing.
Quest Diagnostics Inc's FY2025 package sits #283 by CEO dollars and #219 by ratio under PEAK · STEEP.
Quest Diagnostics Inc's PEAK CEO total is equity-sensitive - read what grant-date fair value does and does not mean.
Data currency: Executive compensation from SEC EDGAR DEF 14A proxy statements through fiscal year 2025, compiled and last refreshed August 2026. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.